Elkfork Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $188K | Buy |
14,476
+440
| +3% | +$5.71K | ﹤0.01% | 839 |
|
|
2019
Q2 | $175K | Hold |
14,036
| – | – | ﹤0.01% | 860 |
|
|
2019
Q1 | $204K | Buy |
14,036
+66
| +0.5% | +$959 | 0.01% | 799 |
|
|
2018
Q4 | $154K | Buy |
13,970
+4,268
| +44% | +$47K | ﹤0.01% | 825 |
|
|
2018
Q3 | $255K | Buy |
9,702
+1,364
| +16% | +$35.9K | 0.01% | 787 |
|
|
2018
Q2 | $171K | Hold |
8,338
| – | – | ﹤0.01% | 834 |
|
|
2018
Q1 | $151K | Buy |
8,338
+44
| +0.5% | +$797 | ﹤0.01% | 857 |
|
|
2017
Q4 | $116K | Buy |
8,294
+572
| +7% | +$8K | ﹤0.01% | 915 |
|
|
2017
Q3 | $143K | Buy |
7,722
+2,354
| +44% | +$43.6K | ﹤0.01% | 822 |
|
|
2017
Q2 | $91K | Buy |
5,368
+2,772
| +107% | +$47K | ﹤0.01% | 886 |
|
|
2017
Q1 | $35K | Sell |
2,596
-484
| -16% | -$6.53K | ﹤0.01% | 957 |
|
|
2016
Q4 | $46K | Buy |
+3,080
| New | +$46K | ﹤0.01% | 890 |
|